Description
Useful adjuvant for prevention of coronary insufficiency, for follow up support such as anti-thrombotic affect after a heart attack and is a good component for genera l heart health
Preventative treatment, or follow-up therapy following a heart attack, must complement the glycoside effects, but not interfere with required allopathic drugs. In addition, the therapy should enable the patient to reduce the dosage of prescribed drugs over time. ADEL 54 (CANGUST) drops provide anti-inflammatory, anti-thrombotic properties that help prevent coronary insufficiency and sclerosis, but do not disrupt therapies. This remedy also prevents hyper-acidification of the heart muscle, making it valuable for prophylaxis of a heart attack.
